Targeted Therapeutics Market Trend, Forecast, Drivers, Restraints, Company Profiles and Key Players Analysis by 2027
Emergen Research Logo
The global targeted therapeutics market size is expected to reach USD 162.89 Billion and register a revenue CAGR of 7.1% over the forecast period, according
VANCOUVER, BC, CANADA, September 22, 2022 /EINPresswire.com/ -- The global targeted therapeutics market size is expected to reach USD 162.89 Billion and register a revenue CAGR of 7.1% over the forecast period, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to increasing prevalence of different cancers. Various drugs for chemotherapy are incapable of differentiating between healthy and cancer cells, and thus can kill both kinds of cells. Targeted therapeutics, on the other hand, is a cancer treatment that makes use of drugs to target the exact proteins and genes that support survival and growth of cancer cells. Using targeted therapeutics, doctors influence the tissue environment that aids the spread of cancer or target cells associated with growth of cancer such as blood vessel cells. Also, targeted therapeutics is frequently used in combination with chemotherapy and other treatments. Over the years, various targeted therapies have been sanctioned by the US Food and Drug Administration, owing to growing prevalence of various kinds of cancers.
Cancer risk rises rapidly with age and it has been found that around 60% cases of cancers are diagnosed in individuals in the age group of 65 years or above. Considering the rising prevalence of cancer among an increasing geriatric population, specialized approaches such as targeted therapeutics are essential for diagnosis and treatment of geriatric patients suffering from cancer. Numerous medically intricate cases of metastatic renal cell carcinoma in geriatrics exhibited survival benefits using targeted therapeutic treatment.
To know about more drivers and challenges | Download a PDF sample now: @ https://www.emergenresearch.com/request-sample/842
Targeted Therapeutics Market Report 2021 is one of a series of new reports from The Emergen Research Company that provides plant factory industry overview, Targeted Therapeutics market analysis and forecasts market size and growth for the global plant factory market, Targeted Therapeutics market segments and geographies, Targeted Therapeutics market players, Targeted Therapeutics market leading competitor revenues, profiles and market shares. The plant factory market research report identifies top countries and segments for opportunities and strategies based on market trends and key competitors’ approaches.
Targeted Therapeutics Market: Analysis by focusing on Competitive landscape and Key Developments
Amgen Inc., Genentech Inc., Arcus Biosciences Inc., Gilead Sciences Inc., AstraZeneca PLC, Serina Therapeutics Inc., F. Hoffmann-La Roche & Co., Agenus Inc., Pfizer Inc., and Aurinia Pharmaceutical Inc.
Access the full study findings here: https://www.emergenresearch.com/industry-report/targeted-therapeutics-market
The research then uncovers market opportunities that are simple and gives the business valuable information that will help it thrive in the global Targeted Therapeutics market. The report contains detailed information on the factors that will increase the market's growth over the next few years, from 2021-2028. The report discusses market segmentation, key players and types of applications, as well as rapid growth in key markets.
key findings from the report suggest
In July 2021, Bicycle Therapeutics PLC, which is a biotechnology firm engaged in development of innovative and differentiated therapeutics class on the basis of its proprietary bicyclic peptide technology called Bicycle, made an announcement about entering into a global collaboration and license contract with Ionis Pharmaceuticals for tissue-targeted delivery of oligonucleotide therapeutics deploying Bicycles with high affinity to transferrin receptor (TfR1).
Among the therapy segments, monoclonal antibodies segment revenue is expected to account for a significantly robust revenue share over the forecast period. Monoclonal antibodies delivering cytotoxic molecules are capable of precisely killing cancer cells. Antibody, after being bound to its target cell, releases toxic molecule, including a poisonous chemical or radioactive substance that is taken up by the target cell and eventually destroys that cell. These toxins do not affect cells devoid of the antibody target. Examples of monoclonal antibody comprise trastuzumab (certain breast cancers), alemtuzumab (certain chronic leukemias), and cetuximab (certain colorectal, head, lung, and neck cancers).
Prostate cancer is the second-most cause of cancer deaths among men in the US. Currently used radiation therapy and prostatectomy are often supplemented with hormonal therapies for prostate cancer treatment. Also, in case of prostate cancer, recurrence is common, and many patients develop metastatic prostate cancer where chemotherapy is moderately effective and required targeted therapeutics after initial therapies.
Targeted therapeutics market in North America accounted for largest revenue share in 2020, attributed to rapid adoption of advanced technologies, increasing incidence of cancer, and high healthcare expenditure. In addition, presence of leading market players such as Pfizer Inc. and Amgen Inc. is expected to support market growth in this region.
Emergen Research has segmented global targeted therapeutics market on the basis of therapy, disease indication, end-use, and region:
Therapy Outlook (Revenue, USD Billion; 2018–2028)
Monoclonal Antibodies
Small Molecule Inhibitors
Disease Indication Outlook (Revenue, USD Billion; 2018–2028)
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Leukemia
Lymphoma
Multiple Sclerosis
Melanoma
Others
End-use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Cancer Treatment Centers
Research Institutes
Others
The study segments the Targeted Therapeutics industry in light of major classification such as product type, potential markets, application, and end-user. This industry assessment for the forecast period, 2021 – 2028 incorporates projections pertaining to the investment feasibility, gross margin, profits, consumption volume, production capability and major market vendors. Likewise, statistics associated with the competitive landscape, shifting consumer behaviour and spending power is showcased and well-explained with the help of treasured resources such as charts, graphs and graphic images, which can be easily incorporated in the business or corporate presentations.
Get an Impressive Discount on this Report@ https://www.emergenresearch.com/request-discount/842
How will the Targeted Therapeutics Market, 2021 to 2028 report help you?
In summary, our 250-page report provides you with the following knowledge:
• Revenue forecasts to 2028 for Targeted Therapeutics Market, 2021 to 2028 Market, with forecasts for include report segmentation and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2028 for four regional and 20 key national markets – See forecasts for the Targeted Therapeutics Market, 2021 to 2028 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Targeted Therapeutics Market, 2021 to 2028.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Key point summary of the report:
The report offers a comprehensive overview of the market size, share, and growth rate in the forecast duration.
It provides details about current scenario, historical data, giving an accurate market forecast for the coming years.
The study categorizes the market on the basis of product types, applications, end users, market value and volume, business verticals, and 5 major regions.
It also offers regional market analysis and forecast for prominent geographies in the sector viz., North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Industry supply chain, sourcing strategy, upstream feedstock, and downstream demand analysis has also been undertaken in the research report.
The study offers a comprehensive understanding of the demand and supply dynamics, including production and consumption rates, and mapping of the overall market.
The report employs different analytical tools including, SWOT analysis, Porter’s five forces analysis, and pricing analysis, to give precise market information.
Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/842
Looking for something else? Here is a list of similar reports by Emergen Research
Thank you for reading the research report. We also offer report customization as per client requirement. Kindly connect with us to know more about the customization feature and our team will offer you the best suited report.
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
